Every clinical study comes with a list of rules about who can participate. These are called eligibility criteria, and they exist to keep volunteers safe and to make the study's results meaningful. If you have ever been told you do not qualify for a trial, the criteria — not anything about you personally — are the reason.
Inclusion and exclusion criteria
Eligibility comes in two parts. Inclusion criteria describe who the study is designed for: things like age range, a specific health condition, or a particular stage of disease. Exclusion criteria describe situations that make participation unsafe or that could make the results harder to interpret, such as certain medications, other medical conditions, or pregnancy.
Why criteria can feel strict
Strict criteria are not arbitrary. They help researchers answer a clear question and protect people whose risks might be higher than the study can safely manage. They also reduce the chance that an unrelated factor will mask whether a treatment is working. As studies move into later phases, criteria often broaden to better reflect real-world patients.
Common factors that affect eligibility
- Age and biological sex
- Specific diagnosis or stage of a condition
- Other ongoing medical conditions
- Current medications and supplements
- Recent surgeries or hospitalizations
- Pregnancy or plans to become pregnant
The screening visit
Even if you appear to qualify on paper, most studies include a screening visit before enrollment. This may involve a medical history review, a physical exam, blood work, or other tests. Screening protects you by confirming the study is a reasonable fit for your current health.
If you don't qualify this time
Not qualifying for one study does not mean you cannot participate in another. Different studies look for different volunteers, and new opportunities open all the time. It can help to keep your contact information up to date so a research team can reach out when a better-matched study becomes available.
Diversity in research
Historically, some groups have been underrepresented in clinical trials, which limits how well study results apply to everyone. Researchers and regulators have placed growing emphasis on enrolling participants of different ages, backgrounds, and life experiences so that approved treatments work for the broader public, not just a narrow slice of it.
